Previous studies have reported that various nanozymes with CAT- and SOD-like activities have been proven effective in treating AKI by neutralizing harmful ROS, which aids in the recovery of kidney function (Wang et al., 2022; Zhang et al., 2021c). Here, SOD1 is linked to acute kidney injury.